Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06943001 · ClinicalTrials.gov registry record · NA

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

A NA study of Obesity and Type 2 Diabetes, sponsored by Baylor College of Medicine.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06943001: Recruiting NA study of Obesity and Type 2 Diabetes, sponsored by Baylor College of Medicine.

NCT06943001 is a NA study of Obesity and Type 2 Diabetes that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 40 participants, below the 81-participant average among 5 other Obesity and Type 2 Diabetes trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06943001, a NA study of Obesity and Type 2 Diabetes, is actively recruiting participants, sponsored by Baylor College of Medicine.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Hispanic adolescents are disproportionately burdened by type 2 diabetes (T2D). Social determinants of health (SDoH) serve as barriers to behavior change and participation in disease prevention efforts, especially among vulnerable adolescents. Telehealth is a potentially effective approach for delivering disease prevention programs as it addresses some SDoH like transportation, childcare needs, and parent work schedules. Unfortunately, there are no theory- or evidence-based telehealth diabetes prevention program for Hispanic adolescents. Therefore the purpose of this study is to adapt an evidence-based diabetes prevention program for delivery via telehealth and to test the feasibility of this study among Hispanic adolescents (12-16 years) with obesity.

Primary Outcome

Feasibility is the primary outcome and will be evaluated using a priori criteria. Recruitment and Data Collection criteria will assess the feasibility of recruiting and retaining participants from community clinics. This will provide information on the availability of high-risk adolescents in community clinics and the feasibility of recruiting and engaging adolescents from this setting. The integrity of Study Protocol criteria will be used to identify the feasible and acceptable intervention dos

Interventions

  • BEHAVIORAL Fit24+

Study Locations (1)

Texas

  • USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-04-12
Est. Completion 2026-08-31
Phase NA
Baylor College of Medicine

616 total trials

What NCT06943001 shows while recruiting

NCT06943001 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 81-participant average among 5 other Obesity and Type 2 Diabetes trials with a reported enrollment target (51% lower).

The record links to 1 condition, with Obesity and Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Fit24+ is the first listed.

NCT06943001 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06943001 about?

NCT06943001 is a clinical study titled "Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents". Hispanic adolescents are disproportionately burdened by type 2 diabetes (T2D). Social determinants of health (SDoH) serve as barriers to behavior change and participation in disease prevention efforts, especially among vulnerable adolescents. Telehealth is a potentially effective approach for delive...

What is the current status of trial NCT06943001?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-04-12. Estimated completion is 2026-08-31.

What conditions does trial NCT06943001 study?

This clinical trial studies the following conditions: Obesity and Type 2 Diabetes.

What interventions are being tested in trial NCT06943001?

The interventions under investigation include: Fit24+ (BEHAVIORAL).

Who is sponsoring clinical trial NCT06943001?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06943001 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity and Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06943001, the US trial registry maintained by the National Library of Medicine. NCT06943001 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.